How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
A Phase I Study to Assess the Safety, Tolerability, Radiation Dosimetry and Efficacy of [177Lu] Lu-PSMA-XT in Patients With Metastatic Prostate Cancer
Description:
This was a multicenter, open-label, phase I study to evaluate the safety, tolerability, radiation dosimetry and efficacy of [177Lu] Lu-PSMA-XT injection in patients with metastatic prostate cancer .
Sponsor:
Jinming Zhang
Contacts:
Jinming Zhang (Principal Investigator)zhangjm301@163.com
(+86)010-66936108
Government Study Link:
NCT07096128 - Click here to see study onClinicalTrials.gov
[177Lu] Lu-PSMA-XT
Isotope(s):
Target(s):
- PSMA
